| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Choroid Plexus | 24 | 2023 | 231 | 11.140 |
Why?
|
| Cerebrospinal Fluid | 16 | 2023 | 534 | 5.600 |
Why?
|
| Blood-Brain Barrier | 8 | 2023 | 1015 | 2.020 |
Why?
|
| Neural Stem Cells | 4 | 2020 | 847 | 1.420 |
Why?
|
| Hydrocephalus | 3 | 2023 | 746 | 1.180 |
Why?
|
| Cerebral Ventricles | 4 | 2023 | 544 | 1.030 |
Why?
|
| Choroid Plexus Neoplasms | 3 | 2022 | 43 | 0.980 |
Why?
|
| Cerebral Cortex | 7 | 2023 | 5705 | 0.920 |
Why?
|
| Central Nervous System | 6 | 2021 | 1354 | 0.910 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2023 | 265 | 0.830 |
Why?
|
| Neurons | 15 | 2019 | 9325 | 0.810 |
Why?
|
| Lateral Ventricles | 3 | 2019 | 145 | 0.760 |
Why?
|
| Neurogenesis | 5 | 2016 | 829 | 0.720 |
Why?
|
| Epithelial Cells | 6 | 2023 | 3678 | 0.720 |
Why?
|
| Fourth Ventricle | 2 | 2021 | 30 | 0.710 |
Why?
|
| Adult Stem Cells | 2 | 2019 | 216 | 0.700 |
Why?
|
| Prosencephalon | 2 | 2019 | 303 | 0.700 |
Why?
|
| Potassium | 2 | 2023 | 1336 | 0.680 |
Why?
|
| Proteome | 3 | 2019 | 1790 | 0.670 |
Why?
|
| Ciliary Body | 1 | 2018 | 172 | 0.600 |
Why?
|
| Language Development | 1 | 2018 | 187 | 0.590 |
Why?
|
| Mice | 31 | 2024 | 81045 | 0.580 |
Why?
|
| Craniofacial Abnormalities | 1 | 2019 | 315 | 0.580 |
Why?
|
| Sodium Channels | 1 | 2018 | 349 | 0.560 |
Why?
|
| Epithelium | 4 | 2022 | 1680 | 0.540 |
Why?
|
| Microcephaly | 2 | 2019 | 430 | 0.540 |
Why?
|
| Neurodegenerative Diseases | 3 | 2017 | 1060 | 0.540 |
Why?
|
| Neural Tube | 1 | 2015 | 46 | 0.540 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2019 | 546 | 0.540 |
Why?
|
| Animals | 44 | 2024 | 168561 | 0.520 |
Why?
|
| Oxidative Stress | 4 | 2022 | 3081 | 0.510 |
Why?
|
| Brain | 13 | 2023 | 26343 | 0.510 |
Why?
|
| Unverricht-Lundborg Syndrome | 2 | 2016 | 2 | 0.500 |
Why?
|
| Ribosomes | 1 | 2018 | 499 | 0.500 |
Why?
|
| Zebrafish | 3 | 2023 | 2990 | 0.490 |
Why?
|
| Antioxidants | 1 | 2022 | 1659 | 0.490 |
Why?
|
| Organoids | 1 | 2020 | 692 | 0.490 |
Why?
|
| Growth Disorders | 1 | 2019 | 643 | 0.490 |
Why?
|
| Pericytes | 1 | 2017 | 291 | 0.480 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 366 | 0.460 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 342 | 0.450 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2013 | 69 | 0.440 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 18006 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 987 | 0.420 |
Why?
|
| Autistic Disorder | 1 | 2020 | 1174 | 0.380 |
Why?
|
| Hippocampus | 3 | 2022 | 3661 | 0.380 |
Why?
|
| Light | 1 | 2017 | 1374 | 0.380 |
Why?
|
| Down-Regulation | 1 | 2018 | 3001 | 0.370 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 830 | 0.370 |
Why?
|
| Cell Death | 5 | 2015 | 1695 | 0.360 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2009 | 36 | 0.350 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 3574 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2018 | 3617 | 0.340 |
Why?
|
| Biological Transport | 3 | 2023 | 2119 | 0.330 |
Why?
|
| Behavior | 1 | 2012 | 560 | 0.330 |
Why?
|
| Signal Transduction | 14 | 2021 | 23387 | 0.320 |
Why?
|
| Neuroepithelial Cells | 2 | 2019 | 22 | 0.320 |
Why?
|
| Hedgehog Proteins | 4 | 2022 | 781 | 0.320 |
Why?
|
| Aging | 3 | 2022 | 8626 | 0.310 |
Why?
|
| Fear | 1 | 2016 | 1436 | 0.300 |
Why?
|
| Calcium | 1 | 2020 | 5753 | 0.300 |
Why?
|
| Longevity | 2 | 2023 | 1069 | 0.290 |
Why?
|
| Attention | 1 | 2017 | 2396 | 0.280 |
Why?
|
| Mitochondria | 1 | 2019 | 3520 | 0.280 |
Why?
|
| Cell Differentiation | 5 | 2021 | 11470 | 0.280 |
Why?
|
| Retina | 1 | 2017 | 2611 | 0.270 |
Why?
|
| Apoptosis | 3 | 2019 | 9715 | 0.260 |
Why?
|
| Migraine Disorders | 1 | 2017 | 1620 | 0.250 |
Why?
|
| Animals, Newborn | 4 | 2021 | 2723 | 0.240 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1613 | 0.210 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2016 | 271 | 0.210 |
Why?
|
| Prealbumin | 1 | 2023 | 210 | 0.200 |
Why?
|
| Schizophrenia | 1 | 2020 | 6874 | 0.200 |
Why?
|
| Embryo, Mammalian | 2 | 2021 | 1692 | 0.200 |
Why?
|
| Cerebral Hemorrhage | 2 | 2023 | 2643 | 0.200 |
Why?
|
| Injections, Intraventricular | 1 | 2021 | 230 | 0.190 |
Why?
|
| Inflammation | 1 | 2020 | 10578 | 0.190 |
Why?
|
| Thyroid Hormones | 1 | 2023 | 390 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2019 | 713 | 0.180 |
Why?
|
| Cell Proliferation | 5 | 2020 | 10472 | 0.180 |
Why?
|
| Isonicotinic Acids | 1 | 2019 | 8 | 0.180 |
Why?
|
| Brain Injuries | 1 | 2012 | 2024 | 0.180 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 9735 | 0.180 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 212 | 0.180 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2020 | 154 | 0.180 |
Why?
|
| Rats | 8 | 2023 | 24265 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 21821 | 0.180 |
Why?
|
| Ependyma | 1 | 2019 | 54 | 0.170 |
Why?
|
| Cerebellum | 5 | 2017 | 1490 | 0.170 |
Why?
|
| GABA Agonists | 1 | 2019 | 111 | 0.170 |
Why?
|
| Cells, Cultured | 8 | 2018 | 19223 | 0.170 |
Why?
|
| Humans | 38 | 2024 | 742088 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 3 | 2019 | 4465 | 0.160 |
Why?
|
| Intracranial Pressure | 1 | 2021 | 326 | 0.160 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 418 | 0.160 |
Why?
|
| Cell Count | 1 | 2022 | 1831 | 0.160 |
Why?
|
| Cell Lineage | 2 | 2021 | 2504 | 0.160 |
Why?
|
| Tight Junctions | 1 | 2020 | 310 | 0.160 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 1152 | 0.160 |
Why?
|
| Ferrets | 1 | 2018 | 194 | 0.160 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 617 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2020 | 558 | 0.150 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 144 | 0.150 |
Why?
|
| Touch | 1 | 2019 | 306 | 0.150 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 5851 | 0.150 |
Why?
|
| Cystatin B | 1 | 2016 | 11 | 0.150 |
Why?
|
| Photophobia | 1 | 2017 | 67 | 0.150 |
Why?
|
| Optic Atrophy | 1 | 2017 | 79 | 0.140 |
Why?
|
| Immunoblotting | 1 | 2019 | 1683 | 0.140 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 1866 | 0.140 |
Why?
|
| Female | 20 | 2023 | 379592 | 0.140 |
Why?
|
| Methotrexate | 1 | 2022 | 1720 | 0.130 |
Why?
|
| Dependovirus | 1 | 2021 | 706 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 1081 | 0.130 |
Why?
|
| Glycolysis | 1 | 2019 | 825 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2023 | 1807 | 0.130 |
Why?
|
| Papillomaviridae | 2 | 2001 | 1118 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1184 | 0.130 |
Why?
|
| Immunity | 1 | 2021 | 1011 | 0.130 |
Why?
|
| Retinoids | 1 | 2015 | 96 | 0.130 |
Why?
|
| Pregnancy | 3 | 2023 | 29087 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2015 | 93 | 0.130 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 589 | 0.130 |
Why?
|
| Viral Vaccines | 1 | 2000 | 636 | 0.130 |
Why?
|
| Sensory Receptor Cells | 1 | 2019 | 487 | 0.120 |
Why?
|
| Nucleoside-Phosphate Kinase | 2 | 2011 | 23 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 4751 | 0.120 |
Why?
|
| Papillomavirus Vaccines | 1 | 2000 | 489 | 0.120 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2015 | 124 | 0.120 |
Why?
|
| Capillaries | 1 | 2017 | 774 | 0.120 |
Why?
|
| Conditioning, Classical | 1 | 2016 | 364 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 21596 | 0.110 |
Why?
|
| Infant | 6 | 2020 | 35070 | 0.110 |
Why?
|
| Spasms, Infantile | 1 | 2017 | 305 | 0.110 |
Why?
|
| Male | 14 | 2023 | 349538 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2001 | 2011 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 502 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4200 | 0.110 |
Why?
|
| Brain Edema | 1 | 2017 | 617 | 0.110 |
Why?
|
| Tretinoin | 2 | 2015 | 516 | 0.110 |
Why?
|
| Models, Biological | 3 | 2010 | 9581 | 0.100 |
Why?
|
| Stem Cells | 3 | 2015 | 3563 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2021 | 1554 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1889 | 0.100 |
Why?
|
| Dissection | 1 | 2013 | 294 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2020 | 4211 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6365 | 0.100 |
Why?
|
| Adherens Junctions | 1 | 2011 | 90 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 2021 | 3420 | 0.100 |
Why?
|
| Trisomy | 1 | 2012 | 266 | 0.090 |
Why?
|
| Cerebrum | 1 | 2012 | 137 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2183 | 0.090 |
Why?
|
| Pedigree | 1 | 2018 | 4646 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3444 | 0.090 |
Why?
|
| Carcinoma | 1 | 2022 | 2374 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 879 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 3760 | 0.090 |
Why?
|
| Olfactory Mucosa | 1 | 2010 | 98 | 0.090 |
Why?
|
| Malformations of Cortical Development | 1 | 2012 | 200 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 657 | 0.090 |
Why?
|
| Galactosides | 1 | 2009 | 50 | 0.090 |
Why?
|
| Mice, Knockout | 5 | 2024 | 14554 | 0.090 |
Why?
|
| Cathepsin B | 1 | 2009 | 82 | 0.090 |
Why?
|
| Cell Movement | 2 | 2018 | 5212 | 0.080 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 1004 | 0.080 |
Why?
|
| Cell Communication | 1 | 2016 | 1619 | 0.080 |
Why?
|
| Oxidants | 1 | 2009 | 164 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 390 | 0.080 |
Why?
|
| Macaca mulatta | 1 | 2015 | 2378 | 0.080 |
Why?
|
| Age Factors | 3 | 2021 | 18355 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2011 | 644 | 0.080 |
Why?
|
| 14-3-3 Proteins | 2 | 2006 | 214 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2006 | 438 | 0.080 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2009 | 270 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 4029 | 0.070 |
Why?
|
| Cognition | 2 | 2024 | 6722 | 0.070 |
Why?
|
| Synapses | 1 | 2016 | 1724 | 0.070 |
Why?
|
| Macrophages | 1 | 2021 | 5655 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2011 | 739 | 0.070 |
Why?
|
| Memory | 1 | 2016 | 2163 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2018 | 40955 | 0.070 |
Why?
|
| Adult | 10 | 2019 | 213712 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 730 | 0.070 |
Why?
|
| Oxygen | 1 | 2017 | 4169 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2885 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 1144 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 12071 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1213 | 0.060 |
Why?
|
| Cell Survival | 5 | 2017 | 5872 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1675 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 2187 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2088 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2009 | 1167 | 0.060 |
Why?
|
| Transfection | 2 | 2009 | 5892 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 2502 | 0.060 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 107 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2006 | 1202 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 2006 | 1782 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2008 | 3701 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2019 | 25575 | 0.050 |
Why?
|
| Pain | 1 | 2017 | 4961 | 0.050 |
Why?
|
| Phenotype | 1 | 2019 | 16331 | 0.050 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 42 | 0.050 |
Why?
|
| Histone Demethylases | 1 | 2024 | 320 | 0.050 |
Why?
|
| Finland | 2 | 2000 | 602 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 1 | 2002 | 220 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2016 | 13029 | 0.050 |
Why?
|
| Child | 5 | 2018 | 77478 | 0.050 |
Why?
|
| Adolescent | 5 | 2018 | 85649 | 0.050 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2001 | 179 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2009 | 8436 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2001 | 405 | 0.050 |
Why?
|
| Calcitonin | 1 | 2001 | 336 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2001 | 346 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3504 | 0.040 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2001 | 369 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2006 | 849 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2003 | 604 | 0.040 |
Why?
|
| Mutation | 2 | 2024 | 29717 | 0.040 |
Why?
|
| Chlamydia trachomatis | 1 | 2001 | 245 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 3847 | 0.040 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2019 | 191 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2001 | 514 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 40054 | 0.040 |
Why?
|
| Maze Learning | 1 | 2019 | 478 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1937 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2001 | 1470 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2006 | 1416 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2011 | 7873 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 677 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 4553 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 7721 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2011 | 3456 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 377 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 386 | 0.030 |
Why?
|
| Cell Line | 3 | 2021 | 15994 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 568 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35342 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2016 | 5180 | 0.030 |
Why?
|
| Transcription Factors | 3 | 2017 | 12164 | 0.030 |
Why?
|
| Edema | 1 | 2017 | 790 | 0.030 |
Why?
|
| Disease Progression | 1 | 2009 | 13256 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.030 |
Why?
|
| Cilia | 1 | 2016 | 463 | 0.030 |
Why?
|
| Chromatin | 1 | 2024 | 2917 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 1814 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 56350 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1882 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2000 | 5062 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9639 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1969 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 8829 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 5867 | 0.020 |
Why?
|
| Electroporation | 1 | 2010 | 251 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2002 | 5019 | 0.020 |
Why?
|
| Organogenesis | 1 | 2010 | 222 | 0.020 |
Why?
|
| Middle Aged | 5 | 2018 | 213127 | 0.020 |
Why?
|
| Leukemia | 1 | 1996 | 1507 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 11363 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6313 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2556 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 1989 | 277 | 0.020 |
Why?
|
| Lymphoma | 1 | 1996 | 1873 | 0.020 |
Why?
|
| Lymphatic Diseases | 1 | 1989 | 324 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2000 | 8297 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3920 | 0.020 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1993 | 622 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2010 | 880 | 0.020 |
Why?
|
| Tumor Virus Infections | 1 | 1989 | 451 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4801 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 4029 | 0.020 |
Why?
|
| Anxiety | 1 | 2019 | 4279 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 7901 | 0.020 |
Why?
|
| Lithium Chloride | 1 | 2004 | 87 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2004 | 238 | 0.020 |
Why?
|
| Antibodies | 1 | 1993 | 2459 | 0.020 |
Why?
|
| Incidence | 2 | 2000 | 20928 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1989 | 1758 | 0.010 |
Why?
|
| Neurotrophin 3 | 1 | 2003 | 59 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3564 | 0.010 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2003 | 106 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2003 | 66 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2004 | 380 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2002 | 107 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2964 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2001 | 399 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 375 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 514 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 2107 | 0.010 |
Why?
|
| Serotyping | 1 | 2001 | 338 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2001 | 215 | 0.010 |
Why?
|
| Cotinine | 1 | 2001 | 206 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 1539 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8425 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9410 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2906 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 2305 | 0.010 |
Why?
|
| Growth Substances | 1 | 2001 | 783 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1996 | 5169 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1996 | 5425 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1284 | 0.010 |
Why?
|
| Serine | 1 | 2002 | 828 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2001 | 1341 | 0.010 |
Why?
|
| Chlamydia Infections | 1 | 2001 | 364 | 0.010 |
Why?
|
| Risk Factors | 2 | 2001 | 72145 | 0.010 |
Why?
|
| Epilepsy | 1 | 2012 | 3301 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 1525 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2001 | 1465 | 0.010 |
Why?
|
| RNA Interference | 1 | 2004 | 2890 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 4886 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2968 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 6474 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1996 | 876 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2001 | 1469 | 0.010 |
Why?
|
| Astrocytes | 1 | 2001 | 1266 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1996 | 13655 | 0.010 |
Why?
|
| Microglia | 1 | 2001 | 1261 | 0.010 |
Why?
|
| Social Security | 1 | 1993 | 100 | 0.010 |
Why?
|
| Logistic Models | 2 | 2001 | 13403 | 0.010 |
Why?
|
| Mobile Health Units | 1 | 1993 | 80 | 0.010 |
Why?
|
| Registries | 2 | 2001 | 8077 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1996 | 2123 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 1993 | 284 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2001 | 13921 | 0.010 |
Why?
|
| Remission Induction | 1 | 1996 | 2384 | 0.010 |
Why?
|
| Aged | 4 | 2015 | 162944 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 1996 | 1269 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 9387 | 0.010 |
Why?
|
| Ploidies | 1 | 1989 | 281 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1989 | 328 | 0.000 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1989 | 285 | 0.000 |
Why?
|
| Causality | 1 | 1993 | 1265 | 0.000 |
Why?
|
| Recurrence | 1 | 1996 | 8333 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 8621 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10943 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1989 | 1040 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2001 | 21719 | 0.000 |
Why?
|
| Population Surveillance | 1 | 1993 | 2616 | 0.000 |
Why?
|
| Hodgkin Disease | 1 | 1989 | 1413 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1989 | 5975 | 0.000 |
Why?
|
| Mass Screening | 1 | 1993 | 5238 | 0.000 |
Why?
|
| Prevalence | 1 | 1993 | 15194 | 0.000 |
Why?
|
| Smoking | 1 | 1993 | 8969 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1993 | 39004 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1996 | 62966 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1993 | 53187 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1996 | 77098 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 57683 | 0.000 |
Why?
|